Literature DB >> 20718689

Dexmedetomidine: pediatric pharmacology, clinical uses and safety.

Felice Su1, Gregory B Hammer.   

Abstract

IMPORTANCE OF THE FIELD: Dexmedetomidine is an α(2)-adrenoceptor agonist with sedative, anxiolytic and analgesic properties. It is used off-label in pediatric patients due to its efficacy and lack of adverse respiratory effects. Dexmedetomidine may cause severe circulatory complications in adults. Despite its popularity, the safety of dexmedetomidine in the pediatric population has not been extensively studied. AREAS COVERED IN THIS REVIEW: This article reviews the current literature (up to 2010) focusing on applications and safety of dexmedetomidine administered to pediatric patients. WHAT THE READER WILL GAIN: Dexmedetomidine is a useful sedative and anxiolytic drug in the pediatric intensive care unit as well as during diagnostic and therapeutic procedures. Deleterious effects of dexmedetomidine include hypotension and bradycardia. Additionally, hypertension may occur during the "loading dose" or with high infusion rates. Few studies have been performed to evaluate the safety of dexmedetomidine in pediatrics. The development of tolerance and withdrawal has not been studied in children. TAKE HOME MESSAGE: Despite its favorable respiratory profile, dexmedetomidine may cause deleterious cardiovascular effects. Close monitoring of circulatory dynamics and judicious titration is recommended. Further studies are needed to better define adverse effects following long-term infusions as well as in special populations such as pre-term infants.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20718689     DOI: 10.1517/14740338.2010.512609

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  29 in total

1.  Preemptive dexmedetomidine to prevent propofol injection pain in children.

Authors:  J Yu; Y Zhang; Y Lu; C Dong
Journal:  Ir J Med Sci       Date:  2014-05-04       Impact factor: 1.568

2.  Characterization of dexmedetomidine dosing and safety in neonates and infants.

Authors:  Lauren M Estkowski; Jennifer L Morris; Elizabeth A Sinclair
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Mar-Apr

Review 3.  [Dexmedetomidine].

Authors:  G Gerresheim; U Schwemmer
Journal:  Anaesthesist       Date:  2013-08       Impact factor: 1.041

4.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

5.  Safety and Effectiveness of Dexmedetomidine in the Pediatric Intensive Care Unit (SAD-PICU).

Authors:  Laura Carney; Jennifer Kendrick; Roxane Carr
Journal:  Can J Hosp Pharm       Date:  2013-01

6.  Pharmacokinetics of Dexmedetomidine in Infants and Children After Orthotopic Liver Transplantation.

Authors:  Mihaela A Damian; Gregory B Hammer; Mohammed H Elkomy; Adam Frymoyer; David R Drover; Felice Su
Journal:  Anesth Analg       Date:  2020-01       Impact factor: 5.108

7.  Perioperative dexmedetomidine reduces emergence agitation without increasing the oculocardiac reflex in children: A systematic review and meta-analysis.

Authors:  Jingyao Song; Shuyan Liu; Bin Fan; Guangyu Li; Qianchuang Sun
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

8.  Dexmedetomidine: New avenues.

Authors:  Anju Grewal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-07

9.  A cannabinoid-intoxicated child treated with dexmedetomidine: a case report.

Authors:  Flora Cipriani; Aldo Mancino; Silvia Maria Pulitanò; Marco Piastra; Giorgio Conti
Journal:  J Med Case Rep       Date:  2015-07-03

10.  Comparison of Adrenal Suppression between Etomidate and Dexmedetomidine in Children with Congenital Heart Disease.

Authors:  Hongbin Gu; Mazhong Zhang; Meihua Cai; Jinfen Liu
Journal:  Med Sci Monit       Date:  2015-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.